iBio, Inc.
IBIO
$0.85
$0.000.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 77.78% | 650.00% | 650.00% | 250.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 77.78% | 650.00% | 650.00% | 250.00% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 77.78% | 650.00% | 650.00% | 250.00% | -- |
| SG&A Expenses | -8.43% | -7.42% | -15.29% | -37.46% | -38.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.71% | -5.77% | -23.33% | -41.13% | -42.55% |
| Operating Income | -11.83% | 7.57% | 24.95% | 41.67% | 43.31% |
| Income Before Tax | -19.00% | 3.91% | 31.48% | 46.52% | 47.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.00% | 3.91% | 31.48% | 46.52% | 47.31% |
| Earnings from Discontinued Operations | -- | 24.88% | 22.15% | 65.89% | 73.49% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.22% | 9.37% | 29.25% | 56.01% | 61.69% |
| EBIT | -11.83% | 7.57% | 24.95% | 41.67% | 43.31% |
| EBITDA | -13.51% | 7.08% | 25.82% | 43.07% | 45.11% |
| EPS Basic | 83.68% | 86.33% | 90.12% | 92.73% | 91.39% |
| Normalized Basic EPS | 77.63% | 86.46% | 89.45% | 89.64% | 85.09% |
| EPS Diluted | 83.68% | 86.33% | 90.11% | 92.73% | 91.39% |
| Normalized Diluted EPS | 77.63% | 86.46% | 89.45% | 89.64% | 85.09% |
| Average Basic Shares Outstanding | 173.73% | 374.89% | 557.65% | 610.92% | 526.76% |
| Average Diluted Shares Outstanding | 173.73% | 374.89% | 557.65% | 610.92% | 526.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |